Of the four unique tetradepsipeptide subunits arising from the four ways in which PF1022Acan be retrosynthetically cleaved, we chose the MeLeu-PheLac-MeLeu-Lacsubunit (tetradepsipeptide 8) because of the commercial availability of iV-Boc-iV-methyl-L-leucine 1 which enabled us to prepare PF1022Ain eleven steps from 1, benzyl 3-phenyl-D-lactate 25) and benzyl D-lactate 36) (Scheme 2). Residues were coupled to produce both ester bonds (1 +2->4 and 1 +3->6) and amide bonds (5+7->8 and 9+10->ll) in 57~95% yields using dicyclohexylcarbodiimide (DCC) and a catalytic amount of 4-dimethylaminopyridine (DMAP)in methylene chloride. Suspected diastereomers seen in the NMRspectra of 4 and 6 were in fact rotamers which were slowly interconverting on the NMRtime scale. The presence of rotamers was indicated by observing the coalescence of seemingly extraneous peaks whensamples were heated to 45°C in the spectrometer. NMRrevealed a high degree of optical purity for 7 (and by implication NOV. 1994 6); here the spectrum was not obscured by rotamers. Wedetermined that most of the extra peaks seen in the spectra of tetradepsipeptide 8 and octadepsipeptide 12 were due to rotamers; the balance were due to diastereomers.
BOC protecting groups were removed (6->7, 8->10 and ll->12) by stirring the substrate in 10% TFA in methylene chloride at room temperature for 30 to 60 minutes (88~97% yields). Benzyl protecting groups were removed (4->5, 8->9 and 12->13) by hydrogenolysis in EtOH using 10% Pd on charcoal in a 5 : 1 weight ratio of substrate to catalyst (90~96% yields). Hydrogenolysis was complete within two to four hours at 3atm; when less catalyst was used, reaction time increased dramatically. After coupling tetradepsipeptides 9 and 10, we found it expedient to remove the Boc protecting group to give 12 before hydrogenolysis of the benzyl ester to give 13; this allowed isolation of octadepsipeptide 13 as a neutral compound.
Macrocyclic ring closure of octadepsipeptide 13 using DCCgave PF1022A in low yield along with similar products which were not identified. Macrocyclization of octadepsipeptide 13 with benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP) and JV-methylmorpholine (NMM)at high dilution in methylene chloride proved more successful. HPLCanalysis of the product mixture showed two major componentsin an 83 : 17 ratio and trace amounts of two other components. The most abundant component was readily separated by preparative HPLCto give a white powder found to be identical to PF1022A (30% yield) by comparing its *H and 13C NMRspectra with published spectra1*. We observed a rotation in methanol of -101°which compares favorably with the reported value of -102°. The infrared and ultraviolet spectra were also identical. The large discrepancy in melting points (149~153°; lit. val., 104~106°) may be due to a difference in crystalline forms. PF1022Ais a good chelator of alkali metal ions as shown by FABmass spectral data. In addition to the molecular ion at 949 (M+H), ions at 971 (M+Na) (for the sodium chelate) and 1081 (M+Cs) (for the cesium chelate) were detected. These chelates arise as artifacts from mass spectral analysis; sodium and cesium are commonresidues from instrument calibration. None of the precursors of PF1022Aformed chelates upon mass spectrometry.
The other major component was shown by NMR to be a mixture of diastereomers (6% yield). This material gave a mass spectrum virtually identical to that of PF1022Aand exhibited the same alkali metal ion chelation ability. Trace amounts of what we presume to be mixtures of other diastereomers were also collected during purification by HPLC; these have not been further analyzed.
Experimental 7V-Boc-iV-methyl-L-leucine was purchased from Bachem. XHand 1 3C NMRspectra were recorded on a Bruker 300MHzspectrometer. El mass spectra were obtained on a Finnegan-Matt 8230B mass spectrometer while FABspectra were obtained on a VGAnalytical 70-SE mass spectrometer. Infrared spectra were recorded on a Digilab Model FTS-40 spectrophotometer. A Perkin-Elmer Lambda 7 was used to record UVspectra. Preparative low pressure chromatography was performed using EMScience Silica Gel 60 (230~400 mesh); elution was with 5~40% EtOAc in hexane. Purification of the final product was achieved by HPLCon a Waters Delta Prep 4000 using a 40 x 200mmWaters Delta Pak C18 column. Optical rotations were measured at 25°. 
Applying the DCC procedure described for compound 6 to A^-Boc-A^-methyl-L-leucine 1 (3.67 g, 14.9mmol), benzyl 3-phenyl-D-lactate 2 (3.83g, 14.9mmol), DCC (3.08g, 14.9mmol), DMAP(91 mg, 0.75 mmol) and CH2C12(75 ml) gave benzyl A^-Boc-7V-methyl-L-leucyl-3-phenyl-D-lactate 4 as a clear, pale yellow oil (6.87g, 95% yield) following low pressure chromatography. *H NMR(300Mz, CDC13) 3 0.89 
6 (2.55 g, 6.26 mmol) was dissolved in CH2C12 containing 10% (v/v) TFA(100 ml). The reaction mixture was stirred 50 minutes and then slowly poured into saturated NaHCO3with rapid stirring. The mixture was transferred to a separatory funnel and shaken. The layers were separated, and the aqueous layer extracted with CH2C12.The organic layers were combined, washed Ar-Boc-Ar-methyl-L-leucyl-3-phenyl-D-lactic acid 5
Benzyl 7V-Boc-A^-methyl-L-leucyl-3-phenyl-D-lactate 4 (6.02 g, 12.4mmol) was dissolved in absolute EtOH (100ml) and hydrogenolyzed for seven hours at 3 atm over 10% palladium on charcoal (667mg). The reaction mixture was flushed with nitrogen, filtered through Celite and concentrated to remove EtOH. The residue was taken up in Et2O, washed with water (4 x ), dried (MgSO4), and filtered. The filtrate was concentrated and dried under high vacuum to give N-Boc-TV-methyl-L-leucyl-S-phenyl-D-lactic acid 5 (4.70 g, 96%yield) as a clear, colorless, viscous oil. This material was used without further purification. *H NMR 
10 (0.96g, 1.65mmol), DMAP (10mg, 0.085mmol), DCC (351 mg, 1.70mmol) and CH2C12 (20 ml) gave benzyl A^- Benzyl Ar-Methyl-L-leucyl-
ll (0.99 g, 0.86 mmol) was dissolved in CH2C12 containing 10% (v/v) TFA (28ml). The reaction mixture was stirred 30 minutes and then processed following the procedure used for compound 7. This gave benzyl A^-methyl- 
78mmol) was dissolved in absolute EtOH (50ml), 10% palladium on charcoal added (154mg) and the mixture hydrogenolyzed for two hours following the 
acid 13 (0.44 g, 0.45 mmol) in CH2C12 (460ml; to give a 10"3 M solution) at 0°C followed by N-methylmorpholine (50/d, 46mg, 0.45 mmol). The reaction mixture was stirred at 0°C for 30 minutes and then at room temperature for 48 hours. The reaction mixture was washed with one-half volume of saturated NH4C1, dried (MgSO4) and concentrated to an orange-colored solid foam (592mg). Upon low pressure chromatography, this material gave optically crude cyclodepsipeptide PF1022A as a white solid foam (217 mg, 50% yield). HPLC analysis showed two major components in an 83 : 17 ratio. These were separated by preparative HPLC using a Waters Delta-Pak C18 column with a 65-90% gradient elution between 0.1% TFA in CH3CN and 0.085% TFAin water at a flow rate of 30 ml/minute and detection at 218 nm. The fractions containing the major component were collected and lyophilized to give optically pure cyclodepsipeptide PF1022A (130mg, 30% yield) as a white powder. The XH and 13C NMRspectra were identical with the published spectra of PF1022A1*. *H NMR (300MHz, CD3OD) S 0.6- 1.0 (m, 24H), 1.1~1.9 (m, 18H) The fractions containing the minor component were collected and lyophilized to give a white powder (25mg, 6% yield). *H NMRshowed this to consist of a mixture of diastereomers.
[a]D -49°(c 1.0, CH3OH). FAB-MS m/z 949 (M+H, C52H76N4O12), 971 (M+Na), 1081 (M+Cs) identical to the mass spectrum of PF1022A.
Conclusion
"Wehave developed a synthesis of the anthelmintic cyclodepsipeptide PF1022Aby a convergent route which takes advantage of the symmetry of the molecule. This route consists of eleven steps and is suitable for the preparation of PF1022A in gram quantities. During the preparation of this manuscript, we learned of a synthesis of PF1022A by Ohyama7).
